난치성 T세포 혈액암종을 타겟하는 CD5 CAR-NK의 선도치료제 도출 및 최적화

Cited 0 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.author김태돈-
dc.contributor.author이수연-
dc.coverage.temporal20230101-20230831-
dc.date.accessioned2023-11-02T16:33:05Z-
dc.date.available2023-11-02T16:33:05Z-
dc.date.issued2023-09-27-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/32924-
dc.format.extent34-
dc.publisher보건복지부-
dc.title난치성 T세포 혈액암종을 타겟하는 CD5 CAR-NK의 선도치료제 도출 및 최적화-
dc.title.alternativeDevelopment and optimization of lead CD5 CAR-NK therapy for T cell malignancies-
dc.typeReport-
dc.contributor.affiliatedAuthor김태돈-
dc.contributor.affiliatedAuthor이수연-
dc.contributor.alternativeNameTae-Don Kim-
dc.contributor.alternativeNameSooyun Lee-
dc.description.sponsorshipAwardTitle난치성 T세포 혈액암종을 타겟하는 CD5 CAR-NK의 선도치료제 도출 및 최적화-
dc.contributor.director김태돈-
Appears in Collections:
Division of A.I. & Biomedical Research > Immunotherapy Research Center > 3. Research Reports
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.